Intellectual Property India Publishes Patent Application for 'Anti-Il23 And Anti-Tnf? Antibodies' Filed by Vetmab Biosciences, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517061710 A) filed by Vetmab Biosciences, Inc., San Diego, on June 27, for 'anti-il23 and anti-tnf? antibodies.'

Inventor(s) include Zhan, Hangjun.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "Provided are various embodiments relating to caninized, felinized, or equinized antibodies that bind canine, feline, and/or equine IL23 and/or TNFa, including bispecific antibodies that bind to both IL23 and TNFa. Such antibodies can be used alone or in combination in methods to treat canine, feline, and/or equine subjects with inflammatory condition...